Corteva files Rule 144 to sell 8,311 shares

Corteva, Inc. filed a Rule 144 notice to sell 8,311 shares of its common stock.

Rhea-AI Filing Summary

Corteva, Inc. filed a Rule 144 notice to sell 8,311 shares of its common stock.

The filing lists specific planned transfers tied to equity awards and an option exercise, including 619 shares from a restricted stock unit vesting on 02/26/2024, 2,081 shares from a performance share award vesting on 01/24/2025, 1,074 shares from a performance share award vesting on 01/27/2026, 226 shares from an RSU vesting on 02/18/2026, and 4,311 shares from a broker-assisted cashless exercise on 02/20/2026.

Insights

Corporate Securities Counsel

Rule 144 notice lists planned transfers of 8,311 Corteva common shares tied to awards and an exercise.

The filing itemizes specific sources: vesting of restricted stock units and performance shares on identified dates and a broker-assisted cashless exercise on 02/20/2026. These are routine, timed transfers commonly reported under resale rules.

Regulatory dependencies are the Rule 144 resale conditions and any applicable holding periods; timing and sale mechanics will depend on whether the securities meet those conditions. Subsequent transaction details will appear in resale reports or broker records.

FAQ

What does Corteva's Form 144 disclose about the shares being sold?

It discloses a planned resale of 8,311 shares of common stock. The filing lists specific transfers tied to RSU vesting, performance share vesting, and a broker-assisted cashless exercise with exact dates and share counts.

Which specific equity awards are listed in the Corteva Form 144?

The filing lists vesting of restricted stock units and performance share awards. Examples include 619 RSUs vesting on 02/26/2024 and 2,081 performance shares vesting on 01/24/2025.

Does the Form 144 show any option exercises for Corteva (CTVA)?

Yes. The notice lists a broker-assisted cashless exercise producing 4,311 shares dated 02/20/2026. The filing ties that share count to the exercise method stated in the table.

Are proceeds or sale destinations shown in the Form 144?

The filing does not state proceeds or buyers. It lists the shares and transaction types (vesting/exercise) but does not disclose sale prices, cash amounts, or purchasers in the provided excerpt.

When are the listed vesting or transfer dates for the Corteva shares?

The filing itemizes dates for each transfer: 02/26/2024 (619 RSUs), 01/24/2025 (2,081 performance shares), 01/27/2026 (1,074 performance shares), 02/18/2026 (226 RSUs), and 02/20/2026 (4,311 exercise shares).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 05:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001775281
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Corteva, Inc.
SEC File Number	001-38710
Address of Issuer	9330 ZIONSVILLE ROAD INDIANAPOLIS INDIANA 46268
Phone	(833) 267-8382
Name of Person for Whose Account the Securities are To Be Sold	TITUS BRIAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	8311	636199.59	672524000	02/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/26/2024	Vesting of restricted stock unit award	Corteva, Inc.			619	02/26/2024	Granted as part of issuer equity compensation
Common Stock	01/24/2025	Vesting of performance share award	Corteva, Inc.			2081	01/24/2025	Granted as part of issuer equity compensation
Common Stock	01/27/2026	Vesting of performance share award	Corteva, Inc.			1074	01/27/2026	Granted as part of issuer equity compensation
Common Stock	02/18/2026	Vesting of restricted stock unit award	Corteva, Inc.			226	02/18/2026	Granted as part of issuer equity compensation
Common Stock	02/20/2026	Exercise of employee stock options	Corteva, Inc.			4311	02/20/2026	Broker assisted cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Brian Titus
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)